Search Results

/

Filter options

People

contact

Eleanor MacDonagh

Head of Financial Services Tax

contact

Majella Egan

Head of Residential Sales

contact

Paula Fearon

Head of Project Services

contact

Ray Hunt

Head of Company Secretarial and Compliance Services

contact

Mark White

Partner and Chair

contact

Michael Murphy

Partner Group Leader

Knowledge

29 January 2024

Data Protection Day 2024

8 December 2023

EMIR Enforcement Action

News

Practices

16 April 2024

Fund Finance

28 April 2017

Derivatives

23 March 2017

Venture Capital

23 March 2017

Tax

23 March 2017

Real Estate

23 March 2017

Professional Indemnity

23 March 2017

Product Liability

23 March 2017

Procurement

23 March 2017

Private Equity

23 March 2017

Pensions and Incentives

23 March 2017

International Disputes

23 March 2017

Intellectual Property

23 March 2017

Health and Safety

23 March 2017

Freedom of Information

23 March 2017

Equity Capital Markets

23 March 2017

Employment

23 March 2017

Disputes

23 March 2017

Debt Capital Markets

28 February 2017

Restructuring and Insolvency

Sectors

23 February 2021

Sustainable Finance

6 July 2020

Healthcare

28 April 2017

Technology

26 April 2017

Retail

25 April 2017

Real Estate

23 March 2017

Start-Ups

23 March 2017

Public Sector

23 March 2017

Media and Entertainment

23 March 2017

Pharma and Life Sciences

23 March 2017

Transport

23 March 2017

FinTech

23 March 2017

Communications

23 March 2017

Betting and Gaming

23 March 2017

Finance

23 March 2017

Aviation Finance

23 March 2017

Agri-Food and Drinks

Case Studies

Sota Orthopaedics Limited (Trading as X-Bolt Orthopaedics)

Sota Orthopaedics Limited (Trading as X-Bolt Orthopaedics)

X-Bolt Orthopaedics is a leading medical device company that has designed and developed a highly innovative and unique range of hip nailing and plating solutions suitable for all hip fractures that require fixation.

Inflection Biosciences Limited

Inflection Biosciences Limited

Inflection Biosciences is an early stage, drug development company which won Start-Up of the Year at the Pharma Industry Awards 2014. Due to the successful pre-clinical testing of treatments that it has licensed and hopes to bring to the market, the company has received upwards of €2.5m in venture capital to date.

Barracuda FX Limited’s Funding Rounds and Subsequent Acquisition

Barracuda FX Limited’s Funding Rounds and Subsequent Acquisition

We advised order management technology specialist Barracuda FX Limited during its rapid early stage growth in relation to an equity investment by the AIB Start Up Accelerator Fund (acting through its manager, ACT Venture Capital) and a subsequent funding round with Enterprise Ireland. In 2019, we advised the shareholders of Barracuda FX Limited in its acquisition by US fixed income and FX trading software provider Broadway Technology.